Cargando…
Prognostic Role of NT-proBNP for in-Hospital and 1-Year Mortality in Patients with Acute Exacerbations of COPD
BACKGROUND AND OBJECTIVE: The association between N-terminal pro B-type natriuretic peptide (NT-proBNP) concentrations and in-hospital and 1-year mortality in acute exacerbations of chronic obstructive pulmonary disease (AECOPD) patients is largely unknown. Our objective was to explore the usefulnes...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955621/ https://www.ncbi.nlm.nih.gov/pubmed/32021144 http://dx.doi.org/10.2147/COPD.S231808 |
_version_ | 1783486971046264832 |
---|---|
author | Li, Haiqing Zeng, Zixiong Cheng, Juan Hu, Guoping Li, Yuqun Wei, Liping Zhou, Yumin Ran, Pixin |
author_facet | Li, Haiqing Zeng, Zixiong Cheng, Juan Hu, Guoping Li, Yuqun Wei, Liping Zhou, Yumin Ran, Pixin |
author_sort | Li, Haiqing |
collection | PubMed |
description | BACKGROUND AND OBJECTIVE: The association between N-terminal pro B-type natriuretic peptide (NT-proBNP) concentrations and in-hospital and 1-year mortality in acute exacerbations of chronic obstructive pulmonary disease (AECOPD) patients is largely unknown. Our objective was to explore the usefulness of NT-proBNP concentrations in AECOPD patients as a prognostic marker for in-hospital and 1-year mortality. METHODS: NT-proBNP levels were measured in patients upon admission and laboratory and clinical data were also recorded. The cut-point for the NT-proBNP concentration level for in-hospital death was obtained using the receiver operating characteristic (ROC) curve. Univariate and multivariate logistic regression and Cox regression were used in the analyses of factors of in-hospital and 1-year mortality. RESULTS: A total of 429 patients were enrolled. Twenty-nine patients died during hospitalization and 59 patients died during the 1-year follow-up. Patients who died in-hospital compared with those in-hospital survivors were older (80.14±6.56 vs 75.93±9.45 years, p=0.003), had a higher percentage of congestive heart failure (65.52% vs 33.75%, p<0.001), had higher NT-proBNP levels (5767.00 (1372.50–12,887.00) vs 236.25 (80.03–1074.75) ng/L, p<0.001), higher neutrophil counts (10.52±5.82 vs 7.70±4.31, p=0.016), higher D-dimer levels (1231.62±1921.29 vs 490.11±830.19, p=0.048), higher blood urea nitrogen levels (9.91±6.33 vs 6.51±4.01 mmol/L, p=0.001), a lower body mass index (19.49±3.57 vs 22.19±4.76, p=0.003), and higher hemoglobin levels (122.34±25.36 vs 130.57±19.63, p=0.034). The area under the ROC curve (AUC) for NT-proBNP concentration was 0.88 (95% confidence interval [CI], 0.84–0.93). NT-proBNP concentrations ≥551.35 ng/L were an independent prognostic factor for both in-hospital and 1-year mortality after adjustment for relative risk (RR) (RR=29.54, 95% CI 3.04–286.63, p=0.004 for the multivariate logistic regression analysis) and hazard ratio (HR) (HR=4.47, 95% CI, 2.38–8.41, p <0.001 for the multivariate cox regression analysis). CONCLUSION: NT-proBNP was a strong and independent predictor of in-hospital and 1-year mortality in AECOPD patients. |
format | Online Article Text |
id | pubmed-6955621 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-69556212020-02-04 Prognostic Role of NT-proBNP for in-Hospital and 1-Year Mortality in Patients with Acute Exacerbations of COPD Li, Haiqing Zeng, Zixiong Cheng, Juan Hu, Guoping Li, Yuqun Wei, Liping Zhou, Yumin Ran, Pixin Int J Chron Obstruct Pulmon Dis Original Research BACKGROUND AND OBJECTIVE: The association between N-terminal pro B-type natriuretic peptide (NT-proBNP) concentrations and in-hospital and 1-year mortality in acute exacerbations of chronic obstructive pulmonary disease (AECOPD) patients is largely unknown. Our objective was to explore the usefulness of NT-proBNP concentrations in AECOPD patients as a prognostic marker for in-hospital and 1-year mortality. METHODS: NT-proBNP levels were measured in patients upon admission and laboratory and clinical data were also recorded. The cut-point for the NT-proBNP concentration level for in-hospital death was obtained using the receiver operating characteristic (ROC) curve. Univariate and multivariate logistic regression and Cox regression were used in the analyses of factors of in-hospital and 1-year mortality. RESULTS: A total of 429 patients were enrolled. Twenty-nine patients died during hospitalization and 59 patients died during the 1-year follow-up. Patients who died in-hospital compared with those in-hospital survivors were older (80.14±6.56 vs 75.93±9.45 years, p=0.003), had a higher percentage of congestive heart failure (65.52% vs 33.75%, p<0.001), had higher NT-proBNP levels (5767.00 (1372.50–12,887.00) vs 236.25 (80.03–1074.75) ng/L, p<0.001), higher neutrophil counts (10.52±5.82 vs 7.70±4.31, p=0.016), higher D-dimer levels (1231.62±1921.29 vs 490.11±830.19, p=0.048), higher blood urea nitrogen levels (9.91±6.33 vs 6.51±4.01 mmol/L, p=0.001), a lower body mass index (19.49±3.57 vs 22.19±4.76, p=0.003), and higher hemoglobin levels (122.34±25.36 vs 130.57±19.63, p=0.034). The area under the ROC curve (AUC) for NT-proBNP concentration was 0.88 (95% confidence interval [CI], 0.84–0.93). NT-proBNP concentrations ≥551.35 ng/L were an independent prognostic factor for both in-hospital and 1-year mortality after adjustment for relative risk (RR) (RR=29.54, 95% CI 3.04–286.63, p=0.004 for the multivariate logistic regression analysis) and hazard ratio (HR) (HR=4.47, 95% CI, 2.38–8.41, p <0.001 for the multivariate cox regression analysis). CONCLUSION: NT-proBNP was a strong and independent predictor of in-hospital and 1-year mortality in AECOPD patients. Dove 2020-01-08 /pmc/articles/PMC6955621/ /pubmed/32021144 http://dx.doi.org/10.2147/COPD.S231808 Text en © 2020 Li et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Li, Haiqing Zeng, Zixiong Cheng, Juan Hu, Guoping Li, Yuqun Wei, Liping Zhou, Yumin Ran, Pixin Prognostic Role of NT-proBNP for in-Hospital and 1-Year Mortality in Patients with Acute Exacerbations of COPD |
title | Prognostic Role of NT-proBNP for in-Hospital and 1-Year Mortality in Patients with Acute Exacerbations of COPD |
title_full | Prognostic Role of NT-proBNP for in-Hospital and 1-Year Mortality in Patients with Acute Exacerbations of COPD |
title_fullStr | Prognostic Role of NT-proBNP for in-Hospital and 1-Year Mortality in Patients with Acute Exacerbations of COPD |
title_full_unstemmed | Prognostic Role of NT-proBNP for in-Hospital and 1-Year Mortality in Patients with Acute Exacerbations of COPD |
title_short | Prognostic Role of NT-proBNP for in-Hospital and 1-Year Mortality in Patients with Acute Exacerbations of COPD |
title_sort | prognostic role of nt-probnp for in-hospital and 1-year mortality in patients with acute exacerbations of copd |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955621/ https://www.ncbi.nlm.nih.gov/pubmed/32021144 http://dx.doi.org/10.2147/COPD.S231808 |
work_keys_str_mv | AT lihaiqing prognosticroleofntprobnpforinhospitaland1yearmortalityinpatientswithacuteexacerbationsofcopd AT zengzixiong prognosticroleofntprobnpforinhospitaland1yearmortalityinpatientswithacuteexacerbationsofcopd AT chengjuan prognosticroleofntprobnpforinhospitaland1yearmortalityinpatientswithacuteexacerbationsofcopd AT huguoping prognosticroleofntprobnpforinhospitaland1yearmortalityinpatientswithacuteexacerbationsofcopd AT liyuqun prognosticroleofntprobnpforinhospitaland1yearmortalityinpatientswithacuteexacerbationsofcopd AT weiliping prognosticroleofntprobnpforinhospitaland1yearmortalityinpatientswithacuteexacerbationsofcopd AT zhouyumin prognosticroleofntprobnpforinhospitaland1yearmortalityinpatientswithacuteexacerbationsofcopd AT ranpixin prognosticroleofntprobnpforinhospitaland1yearmortalityinpatientswithacuteexacerbationsofcopd |